[go: up one dir, main page]

EP3589129A4 - Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés - Google Patents

Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés Download PDF

Info

Publication number
EP3589129A4
EP3589129A4 EP18760302.2A EP18760302A EP3589129A4 EP 3589129 A4 EP3589129 A4 EP 3589129A4 EP 18760302 A EP18760302 A EP 18760302A EP 3589129 A4 EP3589129 A4 EP 3589129A4
Authority
EP
European Patent Office
Prior art keywords
purified
terpens
cannabinoids
useful compositions
compositions selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18760302.2A
Other languages
German (de)
English (en)
Other versions
EP3589129A1 (fr
Inventor
Kurt LEVY
Jonathan Michael COOPER
Jonathan Reed MARTIN
Brian Geoffrey REID
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canopy Growth Corp
Original Assignee
Canopy Growth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/616,874 external-priority patent/US20170266153A1/en
Application filed by Canopy Growth Corp filed Critical Canopy Growth Corp
Publication of EP3589129A1 publication Critical patent/EP3589129A1/fr
Publication of EP3589129A4 publication Critical patent/EP3589129A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
EP18760302.2A 2017-03-01 2018-03-01 Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés Withdrawn EP3589129A4 (fr)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US201762465688P 2017-03-01 2017-03-01
US201762469415P 2017-03-09 2017-03-09
US201762475153P 2017-03-22 2017-03-22
US201762477990P 2017-03-28 2017-03-28
US201762489360P 2017-04-24 2017-04-24
US201762490567P 2017-04-26 2017-04-26
US201762490465P 2017-04-26 2017-04-26
US201762491160P 2017-04-27 2017-04-27
US201762491175P 2017-04-27 2017-04-27
US201762491899P 2017-04-28 2017-04-28
US201762491980P 2017-04-28 2017-04-28
US201762509651P 2017-05-22 2017-05-22
US201762510229P 2017-05-23 2017-05-23
US201762510660P 2017-05-24 2017-05-24
US201762510672P 2017-05-24 2017-05-24
US201762511218P 2017-05-25 2017-05-25
US15/616,874 US20170266153A1 (en) 2015-02-27 2017-06-07 Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
PCT/US2018/020440 WO2018160827A1 (fr) 2017-03-01 2018-03-01 Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés

Publications (2)

Publication Number Publication Date
EP3589129A1 EP3589129A1 (fr) 2020-01-08
EP3589129A4 true EP3589129A4 (fr) 2020-11-25

Family

ID=63370542

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18760302.2A Withdrawn EP3589129A4 (fr) 2017-03-01 2018-03-01 Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés

Country Status (10)

Country Link
EP (1) EP3589129A4 (fr)
CN (1) CN110582206A (fr)
AU (1) AU2018227544A1 (fr)
BR (1) BR112019018088A2 (fr)
CA (1) CA3054690A1 (fr)
CO (1) CO2019009413A2 (fr)
IL (1) IL268929A (fr)
MX (1) MX2019010370A (fr)
PE (1) PE20200383A1 (fr)
WO (1) WO2018160827A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019147690A1 (fr) 2018-01-23 2019-08-01 High Sierra Technologies, Inc. Produits à base de cannabis modifiés par élimination de composés organiques volatils et ajout d'hydrocarbures insaturés volatils
US12458906B2 (en) 2018-01-23 2025-11-04 High Sierra Technologies, Inc. Methods of modifying a naturally occurring cannabis raw plant material, a purified cannabis product from a naturally occurring cannabis raw plant material, and a modified cannabis product from a naturally occurring cannabis raw plant material
IL266151A (en) * 2019-04-18 2019-07-31 Kanabo Res Ltd Dilute for the cannabinoid preparations
US11925907B2 (en) 2019-07-22 2024-03-12 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
BR112022010288A2 (pt) * 2019-11-26 2022-09-27 Lycored Ltd Combinações sinérgicas anti-inflamatórias de canabinoide e licopeno
WO2021220208A1 (fr) * 2020-04-29 2021-11-04 Ligar Limited Partnership Polymères à empreinte et procédés pour leur utilisation
WO2022020944A1 (fr) * 2020-07-27 2022-02-03 Canopy Growth Corporation Procédés de synthèse de cannabielsoin et d'analogues de ceux-ci
WO2022165165A1 (fr) * 2021-01-29 2022-08-04 The Johns Hopkins University Effets de limonène sur l'anxiété induite par tétrahydrocannabinol (thc)
CN113368086B (zh) * 2021-08-11 2021-12-03 龙麻(上海)医药研发有限责任公司 一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
US20250367220A1 (en) * 2022-06-17 2025-12-04 New Growth Brands, Inc. Compositions comprising cannabinoids and methods of preparation and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009019322A1 (de) * 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) * 2010-03-30 2017-05-21 Gw伐瑪有限公司 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途
CA2931039C (fr) * 2013-11-20 2022-07-12 Mary Lynch Compositions et methodes de traitement de l'inflammation oculaire et de la douleur
CA2977802A1 (fr) * 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprenant des combinaisons de cannabinoides purifies, ayant au moins un flavonoide, terpene ou mineral

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
CO2019009413A2 (es) 2019-09-09
IL268929A (en) 2019-10-31
AU2018227544A1 (en) 2019-08-29
CN110582206A (zh) 2019-12-17
CA3054690A1 (fr) 2018-09-07
EP3589129A1 (fr) 2020-01-08
BR112019018088A2 (pt) 2020-03-24
MX2019010370A (es) 2019-10-22
WO2018160827A1 (fr) 2018-09-07
PE20200383A1 (es) 2020-02-24

Similar Documents

Publication Publication Date Title
EP3589129A4 (fr) Compositions sélectionnées de manière ciblée comportant des cannabinoïdes purifiés et/ou des terpènes purifiés
IL293377A (en) Hsd17b13 variants and uses thereof
EP3474820C0 (fr) Compositions glp-1 et ses utilisations
EP3478308A4 (fr) Composition à base de cannabis et procédés
EP3411412A4 (fr) Technologie fit-immunoglobuline et ses utilisations
EP3600284A4 (fr) Compositions vaporisables comprenant du cannabinol
EP3564714A4 (fr) Composition de formation de couche de revêtement dur et lentille de lunettes
EP3481952A4 (fr) Marqueurs de méthylation dans le traitement de la leucémie et leurs utilisations
IL272200A (en) Isochroman compounds and uses thereof
EP3893945A4 (fr) Esters cromoglycique et leurs utilisations
EP3564307A4 (fr) Composition de résine et utilisation de celle-ci
EP3578525A4 (fr) Composition de verre et équipement de cuisson
EP3492502A4 (fr) Composition de polyuréthanne thermodurcissable et son utilisation
EP3702434C0 (fr) Composition lubrifiante
EP3498777A4 (fr) Composition d'émulsion d'organopolysiloxane, et composition de résine
EP3624595A4 (fr) Compositions édulcorées de siaménoside i et leurs utilisations
EP3609504A4 (fr) Nouveaux analogues d'oxaborole et utilisations de ces derniers
EP3538113A4 (fr) Tcr spécifiques d'un antigène t de polyomavirus à cellules de merkel à haute affinité et leurs utilisations
EP3730565A4 (fr) Structure multicouche et ses utilisations
EP3384780C0 (fr) Composition d'huile végétale et ses utilisations
EP3801505A4 (fr) Cannabinoïdes et leurs utilisations
IL271073A (en) B4galt1 variants and uses thereof
EP3497436A4 (fr) Élution et détection
IL264445A (en) Compounds and compositions and uses thereof
EP3752564A4 (fr) Compositions architecturales résistant aux éraflures et résistant aux éclats

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190807

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MARTIN, JONATHAN REED

Inventor name: REID, BRIAN GEOFFREY

Inventor name: COOPER, JONATHAN MICHAEL

Inventor name: LEVY, KURT

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20201022

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/352 20060101ALI20201016BHEP

Ipc: A01N 65/00 20090101AFI20201016BHEP

Ipc: A61K 31/05 20060101ALI20201016BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210521